Mazdutide
Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity
Innovent · Phase 3 · Recruiting · Enrollment 336
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| IBI362 treatment Group | Obesity or overweight | n/r | 1 | n/r | n/r |
| Placebo Control Group | Obesity or overweight | n/r | 1 | n/r | n/r |